E. S. Neiss

543 total citations
33 papers, 388 citations indexed

About

E. S. Neiss is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, E. S. Neiss has authored 33 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 8 papers in Molecular Biology and 7 papers in Pharmacology. Recurrent topics in E. S. Neiss's work include Synthesis and Reactions of Organic Compounds (6 papers), Enzyme function and inhibition (4 papers) and Synthesis and Catalytic Reactions (4 papers). E. S. Neiss is often cited by papers focused on Synthesis and Reactions of Organic Compounds (6 papers), Enzyme function and inhibition (4 papers) and Synthesis and Catalytic Reactions (4 papers). E. S. Neiss collaborates with scholars based in United States, Malaysia and Germany. E. S. Neiss's co-authors include E. Campaigne, Robert A. Vukovich, Atul Khandwala, Ira Weinryb, Bernard Loev, Howard Jones, Stephen M. Coutts, Bruce Williams, Jerry W. Skiles and JOHN H. MUSSER and has published in prestigious journals such as Journal of Medicinal Chemistry, Biochemical Pharmacology and American Heart Journal.

In The Last Decade

E. S. Neiss

31 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. S. Neiss United States 13 123 94 84 73 39 33 388
Barbara A. Bopp United States 12 104 0.8× 188 2.0× 60 0.7× 69 0.9× 16 0.4× 19 494
Arthur M. Strosberg United States 12 227 1.8× 184 2.0× 77 0.9× 67 0.9× 56 1.4× 26 527
Takashi Kariya Japan 10 91 0.7× 203 2.2× 40 0.5× 133 1.8× 56 1.4× 18 449
J. Delarge Belgium 11 173 1.4× 168 1.8× 119 1.4× 58 0.8× 22 0.6× 20 464
William C. Lubawy United States 11 57 0.5× 110 1.2× 52 0.6× 30 0.4× 41 1.1× 40 389
Conny Bogentoft Sweden 14 121 1.0× 165 1.8× 67 0.8× 24 0.3× 54 1.4× 61 617
C. Ray Tallent United States 11 30 0.2× 75 0.8× 66 0.8× 42 0.6× 27 0.7× 19 322
G. Lambelin Canada 11 33 0.3× 65 0.7× 94 1.1× 43 0.6× 23 0.6× 47 322
Elijah H. Gold United States 12 262 2.1× 165 1.8× 49 0.6× 46 0.6× 23 0.6× 21 486
C. G. SCOTT United States 10 48 0.4× 76 0.8× 101 1.2× 62 0.8× 14 0.4× 14 435

Countries citing papers authored by E. S. Neiss

Since Specialization
Citations

This map shows the geographic impact of E. S. Neiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. S. Neiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. S. Neiss more than expected).

Fields of papers citing papers by E. S. Neiss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. S. Neiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. S. Neiss. The network helps show where E. S. Neiss may publish in the future.

Co-authorship network of co-authors of E. S. Neiss

This figure shows the co-authorship network connecting the top 25 collaborators of E. S. Neiss. A scholar is included among the top collaborators of E. S. Neiss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. S. Neiss. E. S. Neiss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Khandwala, Atul, et al.. (1987). REV 2871 (CHBZ): A potent antiallergic agent with a novel mechanism of action. Biochemical Pharmacology. 36(5). 663–672. 3 indexed citations
3.
Skiles, Jerry W., Bruce Williams, Paul R. Menard, et al.. (1986). Angiotensin-converting enzyme inhibitors: new orally active 1,4-thiazepine-2,5-diones, 1,4-thiazine-2,5-diones, and 1,4-benzothiazepine-2,5-diones possessing antihypertensive activity. Journal of Medicinal Chemistry. 29(5). 784–796. 36 indexed citations
4.
Skiles, Jerry W., et al.. (1985). Angiotensin-converting enzyme inhibitors. New orally active antihypertensive (mercaptoalkanoyl)- and [(acylthio)alkanoyl]glycine derivatives. Journal of Medicinal Chemistry. 28(1). 57–66. 20 indexed citations
5.
Matthys, H, et al.. (1985). The Bronchosparing Effect of Celiprolol, A New Beta1‐ Alpha2‐Receptor Antagonist on Pulmonary Function of Propranolol‐Sensitive Asthmatics. The Journal of Clinical Pharmacology. 25(5). 354–359. 13 indexed citations
6.
Menard, Paul R., et al.. (1985). Angiotensin converting enzyme inhibitors. (Mercaptoaroyl)amino acids. Journal of Medicinal Chemistry. 28(3). 328–332. 10 indexed citations
7.
MUSSER, JOHN H., Howard Jones, Stanley Sciortino, et al.. (1985). Synthesis and antiallergic activities of 1,3-oxazolo[4,5-h]quinolines. Journal of Medicinal Chemistry. 28(9). 1255–1259. 12 indexed citations
8.
Godfrey, John C., et al.. (1984). The Efficacy of a Potassium-Sparing Combination of Chlorthalidone and Triamterene in the Control of Mild and Moderate Hypertension. II. Journal of International Medical Research. 12(3). 140–146. 3 indexed citations
9.
Godfrey, John C., et al.. (1984). Chlorthalidone-Triamterene: A Potassium-Sparing Diuretic Combination for the Treatment of Oedema. Journal of International Medical Research. 12(3). 147–153. 2 indexed citations
10.
Godfrey, John C., et al.. (1984). The Efficacy of a Potassium-Sparing Combination of Chlorthalidone and Triamterene in the Control of Mild and Moderate Hypertension. I. Journal of International Medical Research. 12(3). 133–139. 3 indexed citations
11.
Khandwala, Atul, et al.. (1984). Effects of celiprolol (REV 5320), a new cardioselective beta-adrenoceptor antagonist, on in vitro adenylate cyclase, alpha- and beta-adrenergic receptor binding and lipolysis.. PubMed. 272(1). 40–55. 20 indexed citations
12.
Vukovich, Robert A., et al.. (1983). Long-term experience with indapamide. American Heart Journal. 106(1). 258–262. 26 indexed citations
13.
Grebow, Peter E., et al.. (1982). Pharmacokinetics and bioavailability of indapamide ? A new antihypertensive drug. European Journal of Clinical Pharmacology. 22(4). 295–299. 18 indexed citations
14.
Dreyfuss, Jacques, et al.. (1975). Absorption and biotransformation of topically applied 8-(methylthio)cyclic AMP. British Journal of Dermatology. 93(4). 379–390.
15.
Sugerman, A. Arthur, et al.. (1974). Influence of Probenecid and Food on the Bioavailability of Cephradine in Normal Male Subjects. The Journal of Clinical Pharmacology. 14(11). 604–611. 26 indexed citations
16.
Campaigne, E., E. S. Neiss, Carl C. Pfeiffer, & Rainer Beck. (1968). Benzo[b]thiophene derivatives. XII. Synthesis of some 3-benzo[b]thienylalkylamines and comparison of their central nervous system activity with tryptamine isosteres. Journal of Medicinal Chemistry. 11(5). 1049–1054. 15 indexed citations
17.
Campaigne, E., Talmage R. Bosin, & E. S. Neiss. (1967). The Sulfur Analog of Serotonin. Journal of Medicinal Chemistry. 10(2). 270–271. 12 indexed citations
18.
Campaigne, E. & E. S. Neiss. (1966). Benzo[b]thiophene derivatives. VIII. Benzo[b]thiophene‐3‐earboxaldehyde and derivatives. Journal of Heterocyclic Chemistry. 3(1). 46–50. 10 indexed citations
19.
Campaigne, E., Eugene D. Weinberg, Gerald Carlson, & E. S. Neiss. (1965). Benzo[b]thiophene Derivatives. V. Mannich Bases With Antimicrobial Activity1. Journal of Medicinal Chemistry. 8(1). 136–137. 7 indexed citations
20.
Campaigne, E. & E. S. Neiss. (1965). Benzo[b] thiophene derivatives. VI. A symmetrical fused heptacyclic system containing oxygen, sulfur, aromatic and carbocyclic rings. Journal of Heterocyclic Chemistry. 2(1). 100–102. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara A. Bopp Breakdown of academic impact, for papers by Arthur M. Strosberg Breakdown of academic impact, for papers by Takashi Kariya Breakdown of academic impact, for papers by J. Delarge Breakdown of academic impact, for papers by William C. Lubawy Breakdown of academic impact, for papers by Conny Bogentoft Breakdown of academic impact, for papers by C. Ray Tallent Breakdown of academic impact, for papers by G. Lambelin Breakdown of academic impact, for papers by Elijah H. Gold Breakdown of academic impact, for papers by C. G. SCOTT
Rankless by CCL
2026